Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications

Naoyoshi Nagata,Tadashi Takeuchi,Hiroaki Masuoka,Ryo Aoki,Masahiro Ishikane,Noriko Iwamoto,Masaya Sugiyama,Wataru Suda,Yumiko Nakanishi,Junko Terada-Hirashima,Moto Kimura,Tomohiko Nishijima,Hiroshi Inooka,Tohru Miyoshi-Akiyama,Yasushi Kojima,Chikako Shimokawa,Hajime Hisaeda,Fen Zhang,Yun Kit Yeoh,Siew C Ng,Naomi Uemura,Takao Itoi,Masashi Mizokami,Takashi Kawai,Haruhito Sugiyama,Norio Ohmagari,Hiroshi Ohno
DOI: https://doi.org/10.1053/j.gastro.2022.09.024
IF: 29.4
Gastroenterology
Abstract:Background & aims: We investigate interrelationships between gut microbes, metabolites, and cytokines that characterize COVID-19 and its complications, and we validate the results with follow-up, the Japanese 4D (Disease, Drug, Diet, Daily Life) microbiome cohort, and non-Japanese data sets. Methods: We performed shotgun metagenomic sequencing and metabolomics on stools and cytokine measurements on plasma from 112 hospitalized patients with SARS-CoV-2 infection and 112 non-COVID-19 control individuals matched by important confounders. Results: Multiple correlations were found between COVID-19-related microbes (eg, oral microbes and short-chain fatty acid producers) and gut metabolites (eg, branched-chain and aromatic amino acids, short-chain fatty acids, carbohydrates, neurotransmitters, and vitamin B6). Both were also linked to inflammatory cytokine dynamics (eg, interferon γ, interferon λ3, interleukin 6, CXCL-9, and CXCL-10). Such interrelationships were detected highly in severe disease and pneumonia; moderately in the high D-dimer level, kidney dysfunction, and liver dysfunction groups; but rarely in the diarrhea group. We confirmed concordances of altered metabolites (eg, branched-chain amino acids, spermidine, putrescine, and vitamin B6) in COVID-19 with their corresponding microbial functional genes. Results in microbial and metabolomic alterations with severe disease from the cross-sectional data set were partly concordant with those from the follow-up data set. Microbial signatures for COVID-19 were distinct from diabetes, inflammatory bowel disease, and proton-pump inhibitors but overlapping for rheumatoid arthritis. Random forest classifier models using microbiomes can highly predict COVID-19 and severe disease. The microbial signatures for COVID-19 showed moderate concordance between Hong Kong and Japan. Conclusions: Multiomics analysis revealed multiple gut microbe-metabolite-cytokine interrelationships in COVID-19 and COVID-19related complications but few in gastrointestinal complications, suggesting microbiota-mediated immune responses distinct between the organ sites. Our results underscore the existence of a gut-lung axis in COVID-19.
What problem does this paper attempt to address?